معرفی
Dr. Charles Mormando is an Associate Professor in the Department of Psychiatry and Behavioral Health at Pennsylvania State University, affiliated with the Pennsylvania Psychiatric Institute. He holds roles as Interim Medical Director, Medical Director of Admissions, and Associate Director of the Division of Neuromodulation. His work contributes to UN Sustainable Development Goals focused on health and well-being.
Education: Completed an Adult Psychiatry Residency at Stony Brook School of Medicine (2014–2018).
Research Interests:
- Relationship between catatonia and delirium in medical settings
- Subtypes of catatonia and ECT-responsive syndromes
- Nosological classification of mental disorders
Recent Research Focus: Dr. Mormando’s publications emphasize innovative treatments for malignant catatonia, the interface between catatonia and melancholia, and ECT applications in complex cases. His 2025 study explores flumazenil and caffeine in ECT, while 2024 work redefines catatonia-melancholia paradigms.
Awards:
- Best Non-Trainee Research Abstract Award (2022)
- Dean's Award for Excellence in Teaching (2021)
Professional Contributions: Active in clinical teaching and presentations, including grand rounds on catatonia varieties and ECT in transgender patients. Engaged in multidisciplinary teams at the Pennsylvania Psychiatric Institute and Penn State College of Medicine.
